Halted: Johnson & Johnson & the Vaccination Timeline

Halted: Johnson & Johnson & the Vaccination T...

Up next

T-Minus One Week: SpaceX’s IPO 6/5/26

A week out from the SpaceX IPO, WSJ business columnist Tim Higgins discusses the interest from retail investors. While the Nasdaq plans to fast track SpaceX’s entry into the Nasdaq 100 index, the S&P will not be fast tracking the company into its own marquee index. CNBC’s Robert ...  Show more

Bonus: The Path with Becky Quick: The Value of a Life 6/5/26

Noted value investor Guy Spier first gained the public's attention in 2007 when he and a partner paid just over $650,000 at a charity auction to have lunch with the world's most famous investor, Warren Buffett. Spier launched his fund Aquamarine in 1997, following closely to Buff ...  Show more

Recommended Episodes

The Johnson & Johnson Vaccine Pause Explained
The Daily

Federal health agencies on Tuesday called for a pause in the use of Johnson & Johnson’s coronavirus shot as they examine a rare blood-clotting disorder that emerged in six recipients.

Every state, the District of Columbia and Puerto Rico halted their rollout of the Johns ...

  Show more

The J & J Pause, Explained — And What It Means For The U.S. Vaccination Effort
Consider This from NPR

The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ...  Show more

FDA: Johnson & Johnson vaccine is safe and effective
Anderson Cooper 360

The U.S. Food and Drug administration found the Johnson & Johnson coronavirus vaccine is safe and effective and meets the emergency use authorization requirements. If authorized, it’ll be the third shot option in the United States. Dr. Leana Wen is the former Baltimore Health Com ...  Show more

Why Did the U.S. Turn Down Vaccine Doses?
The Daily

From the start of the pandemic, the Trump administration said it was committed to ordering and stockpiling enough potential vaccine doses to end the outbreak in the United States as quickly as possible.

But new reporting from The Times has revealed that Pfizer, the maker ...

  Show more